Found 857 matching trials
Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921) PHASE3 The purpose of this study is to assess the efficacy and safety of the combi...
Show More Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Learn More & Join Trial
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM) PHASE1 This multicenter, open-label, Phase I study will evaluate the safety, effic...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma PHASE3 Radiation therapy is the main treatment for nasopharyngeal carcinoma (NPC),...
Show More Location
Affiliated Hospital of Guangdong Medical University
Learn More & Join Trial
Spinal Versus General Anesthesia With Popliteal and Adductor Canal Blocks for Ambulatory Foot and Ankle Surgery. PHASE4 The purpose of this study is to determine if there is a difference in patie...
Show More Location
Hospital for Special Surgery, New York
Learn More & Join Trial
DEXTENZA for the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery PHASE4 The purpose of this study is to evaluate efficacy and safety of Dextenza fo...
Show More Location
Retina Vitreous Surgeons of Central New York, PC
Learn More & Join Trial
Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma PHASE1 This study has 2 parts: a Dose Escalation Part and a Dose Expansion Part.
...
Show More Location
Multiple Locations
Learn More & Join Trial
Daratumumab (HuMax®-CD38) Safety Study in Multiple Myeloma PHASE2 Establishment of safety profile of HuMax-CD38 when given as monotherapy in ...
Show More Location
Multiple Locations
Learn More & Join Trial
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
Dexamethasone, Dexmedetomidine and Their Combination on Post op. GIT Function Measured by I-FFED Score Post Laparoscopic Cholecystectomy NA The goal of this clinical trial is to learn the effect of Dexamethasone and...
Show More Location
Benha University Hospital
Learn More & Join Trial
Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting PHASE4 This study is being done to determine the efficacies of two preventative dr...
Show More Location
The Ohio State University Wexner Medical Center
Learn More & Join Trial